Literature DB >> 9820588

Cellular distribution of exogenous aprotinin in the rat kidney.

C P Vio1, E Oestreicher, V Olavarria, V Velarde, R K Mayfield, A A Jaffa.   

Abstract

Aprotinin, an inhibitor of the enzymatic activity of kallikrein in vitro, has been used to study the possible contributions of the kallikrein-kinin systems to physiological and pathological conditions. Pharmacokinetic studies indicate that aprotinin is concentrated in the kidney; however, there is little information with regard to its cellular distribution. The purpose of the present work was to study the cellular distribution of aprotinin, which would be valuable for a better understanding of its intrarenal effects. Sprague-Dawley rats (200-250g, n = 36) received aprotinin (50000 KIU/rat) and were killed at different intervals after its administration. The kidneys were examined histologically and the cellular distribution of aprotinin was studied by immunohistochemistry. Aprotinin was localized at 30 min concentrated within vesicles in the apical border of the proximal tubule cells. Later (2 h) it was observed distributed over the cytoplasm, where it remained for the 24 h studied. Aprotinin was also detected in connecting tubule cells colocalized with kallikrein, and in the basal portion of collecting tubule cells. No evidence of endogenous aprotinin was observed. The binding of aprotinin to the connecting tubule cells and collecting ducts offers a partial explanation of its renal effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820588     DOI: 10.1515/bchm.1998.379.10.1271

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  2 in total

1.  Safety of aprotinin in congenital heart operations: results from a large multicenter database.

Authors:  Sara K Pasquali; Matthew Hall; Jennifer S Li; Eric D Peterson; James Jaggers; Andrew J Lodge; Jeffrey P Jacobs; Marshall L Jacobs; Samir S Shah
Journal:  Ann Thorac Surg       Date:  2010-07       Impact factor: 4.330

2.  Comparative effects of aprotinin and human recombinant R24K KD1 on temporal renal function in Long-Evans rats.

Authors:  Prakasha Kempaiah; Leslie A Danielson; Marc Barry; Walter Kisiel
Journal:  J Pharmacol Exp Ther       Date:  2009-09-23       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.